The impact of COVID-19 on future cancer mortality rates
Research type
Research Study
Full title
The impact of COVID-19 on future cancer mortality rates
IRAS ID
295270
Contact name
Andrew Cairns
Contact email
Sponsor organisation
Heriot-Watt University
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
This study concerns the analysis of (rapid) cancer registrations, requested from Public Health England (PHE), for different deprivation groups in nine regions of England, also by age and gender, before and after the COVID-19 pandemic. A variable, namely average age-at-diagnosis, that can reflect delays in cancer diagnosis due to national lockdown, will be derived. Recently, based on comprehensive statistical modelling, we found that a small-to-moderate delay in average cancer diagnosis can result in a significant increase in mortality for certain cancer types. We intend to apply a similar modelling framework, by linking rapid cancer registration numbers with our available cancer mortality data, in order to estimate excess number of cancer deaths due to late diagnosis in 2020.
REC name
Yorkshire & The Humber - Leeds West Research Ethics Committee
REC reference
21/YH/0101
Date of REC Opinion
22 Apr 2021
REC opinion
Favourable Opinion